COMMUNIQUÉS West-GlobeNewswire

-
OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results
30/04/2025 - 22:05 -
Bolt Biotherapeutics Presents Preclinical Results for Next-Generation Boltbody™ ISACs targeting CEA and PD-L1 at AACR Annual Meeting 2025
30/04/2025 - 22:05 -
Iridex to Report First Quarter 2025 Financial Results on May 13, 2025
30/04/2025 - 22:05 -
Vaxart to Present at the Citizens Life Sciences Conference
30/04/2025 - 22:05 -
RxSight, Inc. to Present at the Bank of America Healthcare Conference
30/04/2025 - 22:05 -
Codexis to Report First Quarter 2025 Financial Results on May 14
30/04/2025 - 22:05 -
Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference
30/04/2025 - 22:05 -
Terns Pharmaceuticals to Participate in The Citizens Life Sciences Conference
30/04/2025 - 22:05 -
Revolution Medicines to Report Financial Results for First Quarter 2025 After Market Close on May 7, 2025
30/04/2025 - 22:05 -
Scorpius Holdings Provides 2024 Year-End Business Update; Implements Strategic Cost Reductions and Operational Streamlining
30/04/2025 - 22:05 -
Teladoc Health Reports First Quarter 2025 Results
30/04/2025 - 22:05 -
CooperCompanies Appoints Barbara Carbone to Board of Directors
30/04/2025 - 22:15 -
Best CBD Gummies of 2025: Cornbread Hemp CBD Products Help with Sleep, Pain, and Stress Relief
30/04/2025 - 22:26 -
Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference
30/04/2025 - 22:30 -
LENZ Therapeutics to Report First Quarter 2025 Financial Results and Recent Corporate Highlights on May 7th, 2025
30/04/2025 - 22:30 -
New Study Shows Castle Biosciences’ DecisionDx®-Melanoma Test Outperforms Staging and CP-GEP in Identifying Patients at Low Risk of Sentinel Lymph Node Positivity
30/04/2025 - 23:00 -
Ultragenyx to Host Conference Call for First Quarter 2025 Financial Results and Corporate Update
30/04/2025 - 23:00 -
AdCare Hospital Names New Executive Director to Tackle Growing Addiction Crisis Across Massachusetts
30/04/2025 - 23:42 -
Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq
01/05/2025 - 00:13
Pages